Search Results - Rupert W. Leong
- Showing 1 - 10 results of 10
-
1
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol by Rupert W Leong, Yanna Ko, Patrizia Natale, Aviv Pudipeddi, Tsz Hong Yiu
Published in BMJ Open (2023-10-01)Get full text
Article -
2
-
3
IBD barriers across the continents: a continent-specific analysis – Australasia by Alexander T. Elford, Rupert W. Leong, Emma P. Halmos, Manal Morgan, Kate Kilpatrick, Peter J. Lewindon, Richard B. Gearry, Britt Christensen
Published in Therapeutic Advances in Gastroenterology (2023-09-01)Get full text
Article -
4
Knowledge and perspectives towards the use of histology in inflammatory bowel disease by gastroenterologists across the Asia-Pacific region by Thanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, Hsin-Yun Wu, Julajak Limsrivilai, Wee Chian Lim, Shu-Chen Wei, Rupert W. Leong
Published in Intestinal Research (2025-07-01)Get full text
Article -
5
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission by Marwan E. Majzoub, Sudarshan Paramsothy, Craig Haifer, Rohit Parthasarathy, Thomas J. Borody, Rupert W. Leong, Michael A. Kamm, Nadeem O. Kaakoush
Published in Nature Communications (2024-10-01)Get full text
Article -
6
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling by Marwan E. Majzoub, Laurence D. W. Luu, Craig Haifer, Sudarshan Paramsothy, Thomas J. Borody, Rupert W. Leong, Torsten Thomas, Nadeem O. Kaakoush
Published in mSystems (2024-09-01)Get full text
Article -
7
Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis by Shreeya S. Raich, Marwan E. Majzoub, Craig Haifer, Sudarshan Paramsothy, Md Mushahidul Islam Shamim, Thomas J. Borody, Rupert W. Leong, Nadeem O. Kaakoush
Published in mSystems (2025-10-01)Get full text
Article -
8
Microbiota-targeted strategies in IBD: therapeutic promise of 2′-fucosyllactose and beyond by Nicholas Fanous, Nicholas J. Talley, Thanaboon Chaemsupaphan, Esther Lee, Binod Rayamajhee, Shaghayegh Baradaran Ghavami, Nesa Kazemifard, Hamid Asadzadeh Aghdaei, Emil Chuang, Rupert W. Leong
Published in Therapeutic Advances in Gastroenterology (2025-10-01)Get full text
Article -
9
Adalimumab around the world: comparative analysis of products characteristics and patient support systems by Tsz Hong Yiu, Emilia Anderson, Wai Keung Leung, Hiroshi Nakase, Rupa Banerjee, Huiyu Lin, Christopher Ma, Fernando Magro, Stacy Tse, Bruce E. Sands, Christian Selinger, Rupert W. Leong
Published in Therapeutic Advances in Gastroenterology (2025-10-01)Get full text
Article -
10
Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition by Filiz Akyüz, Yoon Kyo An, Jakob Begun, Satimai Aniwan, Huu Hoang Bui, Webber Chan, Chang Hwan Choi, Nazeer Chopdat, Susan J Connor, Devendra Desai, Emma Flanagan, Taku Kobayashi, Allen Yu-Hung Lai, Rupert W Leong, Alex Hwong-Ruey Leow, Wai Keung Leung, Julajak Limsrivilai, Virly Nanda Muzellina, Kiran Peddi, Zhihua Ran, Shu Chen Wei, Jose Sollano, Michelle Mui Hian Teo, Kaichun Wu, Byong Duk Ye, Choon Jin Ooi
Published in Intestinal Research (2025-01-01)Get full text
Article
